GermanyOther
Pharmaceutical Discount Agreement for the Active Substance Concizumab (Alhemo®)
The procurement involves a pharmaceutical discount agreement related to the active substance Concizumab (Alhemo®). The estimated total value is 216,000 EUR.
- Estimated value
- €216,000
- Published
- 29 Sept 2026
- CPV
- 33600000
Get help from a local consultant
Bidding cross-border? A Baltmodus consultant who works in this market can help you prepare and submit.
Find a consultant